Safety fears over drug hyped to treat the coronavirus spark global confusion

Heidi Ledford

Nature, 2020, vol. 582, issue 7810, 18-19

Abstract: A study that suggested using hydroxychloroquine — a malaria drug — to treat people with COVID-19 could be dangerous has slowed clinical trials, but the study itself has also been questioned.

Keywords: SARS-CoV-2; Drug discovery; Medical research; Malaria (search for similar items in EconPapers)
Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-020-01599-9 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:582:y:2020:i:7810:d:10.1038_d41586-020-01599-9

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-020-01599-9

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().